NVS

Novartis reports Q1 profit up on divestitures

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

[$$] Novartis Profit Rises

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

[$$] Novartis First-Quarter Profit Rises

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

[$$] Glaxo, Novartis Keep Deal-Making on Target

[at The Wall Street Journal] – Worries have been mounting about the threat of mega-mergers in the pharmaceuticals sector. Tuesday’s deals between Novartis, GlaxoSmithKline and Eli Lilly should help allay concerns of a return to ill-fated … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click […]

[$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands

[at The Wall Street Journal] – In combining their consumer-health businesses, GlaxoSmithKline and Novartis are creating a giant that unites some of the world’s best-known brands. moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

[$$] Deals Reshape Novartis, Glaxo

[at The Wall Street Journal] – Novartis and GlaxoSmithKline unveiled a series of transactions worth more than $20 billion that fundamentally transforms both companies. moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

[$$] Glaxo, Novartis Keep Deal-Making on Target

[at The Wall Street Journal] – Worries have been mounting about the threat of mega-mergers in the pharmaceuticals sector. Tuesday’s deals between Novartis, GlaxoSmithKline and Eli Lilly should help allay concerns of a return to ill-fated … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click […]